Clinical trial · Observational
Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute
Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian
NCT05607186CI-TRIAL-00061999completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a retrospective cohort study that aims to evaluate the correlation of magnetic resonance tumour regression grade (mrTRG) and pathological TRG (pTRG) of locally advanced rectal cancer after neoadjuvant long course chemoradiotherapy as well as the prognostic value of mrTRG on survival.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oncology | — | UNRESOLVED | — |
| Rectal Cancer | Malignant Rectal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| neoadjuvant long course chemoradiotherapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Correlation between mrTRG and pTRG
- timeFrame
- Between 1 Jan 2011 to 31 Dec 2016
Secondary outcomes (1)
- measure
- Prognostic value of mrTRG on survival outcomes of rectal cancer patients
- timeFrame
- Between 1 Jan 2011 to 31 Dec 2016
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Rectal cancer * At least 1 high risk feature on MRI * Undergo long course neoadjuvant chemoradiotherapy (LCCRT) Exclusion Criteria: * metastatic disease * Patients who undergo short course radiotherapy * Patients without a repeat MRI after completion of LCCRT
References
Publications (0)
Data not yet available
No reference posted for this study.